市場調查報告書

注射型藥物輸送 - 全球市場的未來展望(2017-2026)

Injectable Drug Delivery - Global Market Outlook (2017-2026)

出版商 Stratistics Market Research Consulting 商品編碼 521402
出版日期 內容資訊 英文 173 Pages
商品交期: 2-3個工作天內
價格
Back to Top
注射型藥物輸送 - 全球市場的未來展望(2017-2026) Injectable Drug Delivery - Global Market Outlook (2017-2026)
出版日期: 2018年08月01日內容資訊: 英文 173 Pages
簡介

全球注射型藥物輸送市場2017年是4,041億4,000萬美金。今後預計以12.8%的年複合成長率擴大,2026年達到1兆1,998億9,000萬美元。

本報告提供注射型藥物輸送的全球市場調查,市場概要,各類型、製劑容器、給藥部位、用途、終端用戶、地區的市場趨勢,市場規模的變化與預測,市場促進、阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 摘要整理

第2章 簡介

第3章 市場趨勢分析

  • 簡介
  • 成長要素
  • 阻礙因素
  • 市場機會
  • 威脅
  • 應用分析
  • 終端用戶分析
  • 新興市場
  • 今後的市場情況

第4章 波特的五力分析

  • 供應商談判力
  • 買方議價能力
  • 替代品的威脅
  • 新加入廠商的威脅
  • 產業內的競爭

第5章 注射型藥物輸送市場:各類型

  • 簡介
  • 製劑
    • 新藥物輸送製劑
    • 傳統藥物輸送
    • 長時間作用型 (持續型) 注射製劑
  • 設備
    • 傳統注射設備
    • 自行注射設備
    • 整合安全注射器
    • 貼片注射器
    • 安全注射器
    • 皮下輸液設備
    • 其他

第6章 注射型藥物輸送市場:各製劑容器

  • 簡介
  • 濾芯
  • 安瓿
  • 小瓶

第7章 注射型藥物輸送市場:各使用模式

  • 簡介
  • 疫苗接種
  • 治療
  • 其他

第8章 注射型藥物輸送市場:各使用設施

  • 簡介
  • 居家醫療現場
  • 醫院、診療所
  • 其他

第9章 注射型藥物輸送市場:各給藥部位

  • 簡介
  • 循環/肌肉骨骼(靜脈內,心臟內,肌肉內,腹膜內)
  • 皮膚(皮內及皮下)
  • 中樞神經系統(大腦內及蜘蛛膜下)
  • 內臟器官(玻璃體內及關節內)

第10章 注射型藥物輸送市場:各用途

  • 簡介
  • 荷爾蒙障礙
    • 貧血
    • 抗血栓症/血栓溶解療法
    • 生長激素缺乏症(GHD)
    • 糖尿病
    • 骨質疏鬆症
    • 生殖健康疾病
  • 自體免疫疾病
    • 多發性硬化症(MS)
    • 乾癬
    • 類風濕性關節炎
    • 克隆氏症
    • 其他
  • 癌症
  • 罕見疾病
  • 心血管疾病
  • 神經病變性中毒
  • 呼吸疾病
  • 再生醫療
  • 腫瘤學
  • 其他
    • 美容治療
    • 疼痛管理
    • 血友病
    • C型肝炎
    • 過敏

第11章 注射型藥物輸送市場:各流通管道

  • 簡介
  • 零售藥局
  • 醫院
  • 電子商務

第12章 注射型藥物輸送市場:各終端用戶

  • 簡介
  • 門診病人照護
  • 家庭
  • 醫院、診療所
  • 其他

第13章 注射型藥物輸送市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他
  • 南美
    • 阿根廷
    • 巴西
    • 智利
    • 其他
  • 中東、非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他

第14章 市場主要趨勢

  • 協定,夥伴關係,聯盟,合資企業
  • 收購與合併
  • 新產品的銷售
  • 擴大策略
  • 其他主要策略

第15章 企業簡介

  • Baxter International, Inc.
  • ELI Lilly and Company
  • Terumo Corporation
  • Becton, Dickinson and Company
  • Pfizer, Inc.
  • Gerresheimer AG
  • Teva Pharmaceutical Industries Ltd.
  • Schott AG
  • Sandoz
  • Antares Pharma, Inc.,
  • Zogenix, Inc.
  • Scandinavian Health Limited
  • Terumo Medical Corp.,
  • Ypsomed Holding AG
  • Unilife Corporation,
  • Vetter Pharma-Fertigung GmbH & Co. KG.
  • Nova Nordisk A/S

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

According to Stratistics MRC, the Global Injectable Drug Delivery market is expected to grow from $404.14 billion in 2017 to reach $1199.89 billion by 2026 with a CAGR of 12.8%. Increasing prevalence of chronic diseases, expansion in the biologics market and technological advances in the form of nanotechnologies are some of the factors propelling the market growth. However, growing injuries and the infections caused by needles is hampering the market growth.

Drug delivery is the method of administering a pharmaceutical compound into the body through different routes to achieve a therapeutic effect. Oral, injection-based, transdermal, and carrier-based are some of the types of drug delivery devices. Injectable drug delivery facilitates the rapid transport of a drug into the body by passing first-pass metabolism. It also helps in administering drugs in unconscious and comatose patients. It is used in conditions such as hormonal imbalance, cystic fibrosis, autoimmune diseases, pain, Wilson's disease, hemophilia, hepatitis C and ribose-5-phosphate isomerase deficiency.

Based on formulation packaging, Ampules segment has a significant growth in the market owing to its good barrier properties as compared to other types of packaging. In addition they offer better protection at a lesser cost, ease of transportation and low costs of manufacturing are the factors driving the market in this segment.

By Geography, North America was estimated to be the largest share for the market during the forecast period. The growth is attributed to the rising dominance of chronic diseases and the number of companies that are focused on collaboration and partnerships to ensure the availability of high-value products.

Some of the key players in the Injectable Drug Delivery market include Baxter International, Inc., ELI Lilly and Company, Terumo Corporation, Becton, Dickinson and Company, Pfizer, Inc., Gerresheimer AG, Teva Pharmaceutical Industries Ltd., Schott AG, Sandoz, Antares Pharma, Inc., Zogenix, Inc., Scandinavian Health Limited, Terumo Medical Corp., Ypsomed Holding AG, Unilife Corporation, Vetter Pharma-Fertigung GmbH & Co. KG and Nova Nordisk A/S.

Types Covered:

  • Formulations
  • Devices

Formulation Packagings Covered:

  • Cartridges
  • Ampules
  • Bottles
  • Vials

Usage Patterns Covered:

  • Immunization
  • Curative Care
  • Other Usage Patterns

Facility of Uses Covered:

  • Home Care Settings
  • Hospitals and Clinics
  • Other Facilities of Use

Site of Administrations Covered:

  • Circulatory/Musculoskeletal System (Intravenous, Intracardiac, Intramuscular, and Intraperitoneal)
  • Skin (Intradermal and Subcutaneous)
  • Central Nervous System (Intracerebral and Intrathecal)
  • Organs (Intravitreal and Intra-Articular)

Applications Covered:

  • Hormonal Disorders
  • Autoimmune Diseases
  • Cancer
  • Orphan Diseases
  • Cardiovascular diseases
  • Neurology Addiction
  • Respiratory Diseases
  • Regenerative Medicine
  • Oncology
  • Other Therapeutic Applications

Distribution Channels Covered:

  • Retail Pharmacy Stores
  • Hospitals
  • E-Commerce

End Users Covered:

  • Ambulatory Care
  • Home Based
  • Clinics/Physician Offices
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends.
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements.

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Futuristic Market Scenario

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Injectable Drug Delivery Market, By Type

  • 5.1 Introduction
  • 5.2 Formulations
    • 5.2.1 Novel Drug Delivery Formulations
      • 5.2.1.1 Microparticles
      • 5.2.1.1.1 Microcapsules
      • 5.2.1.1.2 Microspheres
      • 5.2.1.2 Colloidal Dispersions
      • 5.2.1.2.1 Polymeric/Mixed Micelles
      • 5.2.1.2.2 Niosomes
      • 5.2.1.2.3 Liposomes
      • 5.2.1.2.4 Nanoparticles
      • 5.2.1.2.4.1 Nanoemulsions
      • 5.2.1.2.4.2 Solid-Lipid Nanoparticles
      • 5.2.1.2.4.3 Nanosuspensions
    • 5.2.2 Conventional Drug Delivery Formulations
      • 5.2.2.1 Reconstituted/Lyophilized Formulations
      • 5.2.2.2 Emulsions
      • 5.2.2.3 Solutions
      • 5.2.2.4 Suspensions
    • 5.2.3 Long-Acting Injection Formulations
  • 5.3 Devices
    • 5.3.1 Conventional Injection Devices
      • 5.3.1.1 Material
      • 5.3.1.1.1 Plastic
      • 5.3.1.1.2 Glass
      • 5.3.1.2 Usability
      • 5.3.1.2.1 Disposable Injection Devices
      • 5.3.1.2.2 Reusable Injection Devices
      • 5.3.1.3 Product
      • 5.3.1.3.1 Prefilled Syringes
      • 5.3.1.3.2 Fillable Syringes
    • 5.3.2 Self-Injection Devices
      • 5.3.2.1 Needle-Free Injectors
      • 5.3.2.1.1 Technology
      • 5.3.2.1.1.1 Spring-Based Needle-Free Injectors
      • 5.3.2.1.1.2 Vibration-Based Needle-Free Injectors
      • 5.3.2.1.1.3 Jet-Based Needle-Free Injectors
      • 5.3.2.1.1.4 Laser-Powered Needle-Free Injectors
      • 5.3.2.1.2 Product
      • 5.3.2.1.2.1 Prefilled Needle-Free Injectors
      • 5.3.2.1.2.2 Fillable Needle-Free Injectors
      • 5.3.2.1.3 Usability
      • 5.3.2.1.3.1 Disposable Needle-Free Injectors
      • 5.3.2.1.3.2 Reusable Needle-Free Injectors
      • 5.3.2.2 Autoinjectors
      • 5.3.2.2.1 Design
      • 5.3.2.2.1.1 Customized Autoinjectors
      • 5.3.2.2.1.2 Standardized Autoinjectors
      • 5.3.2.2.2 Technology
      • 5.3.2.2.2.1 Manual Autoinjectors
      • 5.3.2.2.2.2 Automated Autoinjectors
      • 5.3.2.2.3 Product
      • 5.3.2.2.3.1 Prefilled Autoinjectors
      • 5.3.2.2.3.2 Fillable Autoinjectors
      • 5.3.2.2.4 Usability
      • 5.3.2.2.4.1 Disposable Autoinjectors
      • 5.3.2.2.4.2 Reusable Autoinjectors
      • 5.3.2.3 Pen Injectors
      • 5.3.2.3.1 Design
      • 5.3.2.3.1.1 Customized Pen Injectors
      • 5.3.2.3.1.2 Standard Pen Injectors
      • 5.3.2.3.2 Product
      • 5.3.2.3.2.1 Dual-Chambered Pen Injectors
      • 5.3.2.3.2.2 Single-Chambered Pen Injectors
      • 5.3.2.3.3 Usability
      • 5.3.2.3.3.1 Disposable Pen Injectors
      • 5.3.2.3.3.2 Reusable Pen Injectors
      • 5.3.2.4 Wearable Injectors
    • 5.3.3 Integrated safety syringes
    • 5.3.4 Patch injectors
    • 5.3.5 Safety Syringes
    • 5.3.6 Subcutaneous infusion devices
    • 5.3.7 Other Devices

6 Global Injectable Drug Delivery Market, By Formulation Packaging

  • 6.1 Introduction
  • 6.2 Cartridges
  • 6.3 Ampules
  • 6.4 Bottles
  • 6.5 Vials

7 Global Injectable Drug Delivery Market, By Usage Pattern

  • 7.1 Introduction
  • 7.2 Immunization
  • 7.3 Curative Care
  • 7.4 Other Usage Patterns

8 Global Injectable Drug Delivery Market, By Facility of Use

  • 8.1 Introduction
  • 8.2 Home Care Settings
  • 8.3 Hospitals and Clinics
  • 8.4 Other Facilities of Use

9 Global Injectable Drug Delivery Market, By Site of Administration

  • 9.1 Introduction
  • 9.2 Circulatory/Musculoskeletal System (Intravenous, Intracardiac, Intramuscular, and Intraperitoneal)
  • 9.3 Skin (Intradermal and Subcutaneous)
  • 9.4 Central Nervous System (Intracerebral and Intrathecal)
  • 9.5 Organs (Intravitreal and Intra-Articular)

10 Global Injectable Drug Delivery Market, By Application

  • 10.1 Introduction
  • 10.2 Hormonal Disorders
    • 10.2.1 Anemia
    • 10.2.2 Antithrombotic/Thrombolytic Therapy
    • 10.2.3 Growth Hormone Deficiency (GHD)
    • 10.2.4 Diabetes
    • 10.2.5 Osteoporosis
    • 10.2.6 Reproductive Health Disease
  • 10.3 Autoimmune Diseases
    • 10.3.1 Multiple Sclerosis (MS)
    • 10.3.2 Psoriasis
    • 10.3.3 Rheumatoid Arthritis
    • 10.3.4 Crohn's Disease
    • 10.3.5 Other Autoimmune Diseases
  • 10.4 Cancer
  • 10.5 Orphan Diseases
  • 10.6 Cardiovascular diseases
  • 10.7 Neurology Addiction
  • 10.8 Respiratory Diseases
  • 10.9 Regenerative Medicine
  • 10.10 Oncology
  • 10.11 Other Therapeutic Applications
    • 10.11.1 Aesthetic Treatment
    • 10.11.2 Pain Management
    • 10.11.3 Hemophilia
    • 10.11.4 Hepatitis C
    • 10.11.5 Allergies

11 Global Injectable Drug Delivery Market, By Distribution Channel

  • 11.1 Introduction
  • 11.2 Retail Pharmacy Stores
  • 11.3 Hospitals
  • 11.4 E-Commerce

12 Global Injectable Drug Delivery Market, By End User

  • 12.1 Introduction
  • 12.2 Ambulatory Care
  • 12.3 Home Based
  • 12.4 Clinics/Physician Offices
  • 12.5 Other End Users

13 Global Injectable Drug Delivery Market, By Geography

  • 13.1 Introduction
  • 13.2 North America
    • 13.2.1 US
    • 13.2.2 Canada
    • 13.2.3 Mexico
  • 13.3 Europe
    • 13.3.1 Germany
    • 13.3.2 UK
    • 13.3.3 Italy
    • 13.3.4 France
    • 13.3.5 Spain
    • 13.3.6 Rest of Europe
  • 13.4 Asia Pacific
    • 13.4.1 Japan
    • 13.4.2 China
    • 13.4.3 India
    • 13.4.4 Australia
    • 13.4.5 New Zealand
    • 13.4.6 South Korea
    • 13.4.7 Rest of Asia Pacific
  • 13.5 South America
    • 13.5.1 Argentina
    • 13.5.2 Brazil
    • 13.5.3 Chile
    • 13.5.4 Rest of South America
  • 13.6 Middle East & Africa
    • 13.6.1 Saudi Arabia
    • 13.6.2 UAE
    • 13.6.3 Qatar
    • 13.6.4 South Africa
    • 13.6.5 Rest of Middle East & Africa

14 Key Developments

  • 14.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 14.2 Acquisitions & Mergers
  • 14.3 New Product Launch
  • 14.4 Expansions
  • 14.5 Other Key Strategies

15 Company Profiling

  • 15.1 Baxter International, Inc.
  • 15.2 ELI Lilly and Company
  • 15.3 Terumo Corporation
  • 15.4 Becton, Dickinson and Company
  • 15.5 Pfizer, Inc.
  • 15.6 Gerresheimer AG
  • 15.7 Teva Pharmaceutical Industries Ltd.
  • 15.8 Schott AG
  • 15.9 Sandoz
  • 15.1 Antares Pharma, Inc.,
  • 15.11 Zogenix, Inc.
  • 15.12 Scandinavian Health Limited
  • 15.13 Terumo Medical Corp.,
  • 15.14 Ypsomed Holding AG
  • 15.15 Unilife Corporation,
  • 15.16 Vetter Pharma-Fertigung GmbH & Co. KG.
  • 15.17 Nova Nordisk A/S

List of Tables

  • Table 1 Global Injectable Drug Delivery Market Outlook, By Region (2016-2026) ($MN)
  • Table 2 Global Injectable Drug Delivery Market Outlook, By Type (2016-2026) ($MN)
  • Table 3 Global Injectable Drug Delivery Market Outlook, By Formulations (2016-2026) ($MN)
  • Table 4 Global Injectable Drug Delivery Market Outlook, By Novel Drug Delivery Formulations (2016-2026) ($MN)
  • Table 5 Global Injectable Drug Delivery Market Outlook, By Conventional Drug Delivery Formulations (2016-2026) ($MN)
  • Table 6 Global Injectable Drug Delivery Market Outlook, By Long-Acting Injection Formulations (2016-2026) ($MN)
  • Table 7 Global Injectable Drug Delivery Market Outlook, By Devices (2016-2026) ($MN)
  • Table 8 Global Injectable Drug Delivery Market Outlook, By Conventional Injection Devices (2016-2026) ($MN)
  • Table 9 Global Injectable Drug Delivery Market Outlook, By Self-Injection Devices (2016-2026) ($MN)
  • Table 10 Global Injectable Drug Delivery Market Outlook, By Integrated safety syringes (2016-2026) ($MN)
  • Table 11 Global Injectable Drug Delivery Market Outlook, By Patch injectors (2016-2026) ($MN)
  • Table 12 Global Injectable Drug Delivery Market Outlook, By Safety Syringes (2016-2026) ($MN)
  • Table 13 Global Injectable Drug Delivery Market Outlook, By Subcutaneous infusion devices (2016-2026) ($MN)
  • Table 14 Global Injectable Drug Delivery Market Outlook, By Other Devices (2016-2026) ($MN)
  • Table 15 Global Injectable Drug Delivery Market Outlook, By Formulation Packaging (2016-2026) ($MN)
  • Table 16 Global Injectable Drug Delivery Market Outlook, By Cartridges (2016-2026) ($MN)
  • Table 17 Global Injectable Drug Delivery Market Outlook, By Ampules (2016-2026) ($MN)
  • Table 18 Global Injectable Drug Delivery Market Outlook, By Bottles (2016-2026) ($MN)
  • Table 19 Global Injectable Drug Delivery Market Outlook, By Vials (2016-2026) ($MN)
  • Table 20 Global Injectable Drug Delivery Market Outlook, By Usage Pattern (2016-2026) ($MN)
  • Table 21 Global Injectable Drug Delivery Market Outlook, By Immunization (2016-2026) ($MN)
  • Table 22 Global Injectable Drug Delivery Market Outlook, By Curative Care (2016-2026) ($MN)
  • Table 23 Global Injectable Drug Delivery Market Outlook, By Other Usage Patterns (2016-2026) ($MN)
  • Table 24 Global Injectable Drug Delivery Market Outlook, By Facility of Use (2016-2026) ($MN)
  • Table 25 Global Injectable Drug Delivery Market Outlook, By Home Care Settings (2016-2026) ($MN)
  • Table 26 Global Injectable Drug Delivery Market Outlook, By Hospitals and Clinics (2016-2026) ($MN)
  • Table 27 Global Injectable Drug Delivery Market Outlook, By Other Facilities of Use (2016-2026) ($MN)
  • Table 28 Global Injectable Drug Delivery Market Outlook, By Site of Administration (2016-2026) ($MN)
  • Table 29 Global Injectable Drug Delivery Market Outlook, By Circulatory/Musculoskeletal System (Intravenous, Intracardiac, Intramuscular, and Intraperitoneal) (2016-2026) ($MN)
  • Table 30 Global Injectable Drug Delivery Market Outlook, By Skin (Intradermal and Subcutaneous) (2016-2026) ($MN)
  • Table 31 Global Injectable Drug Delivery Market Outlook, By Central Nervous System (Intracerebral and Intrathecal) (2016-2026) ($MN)
  • Table 32 Global Injectable Drug Delivery Market Outlook, By Organs (Intravitreal and Intra-Articular) (2016-2026) ($MN)
  • Table 33 Global Injectable Drug Delivery Market Outlook, By Application (2016-2026) ($MN)
  • Table 34 Global Injectable Drug Delivery Market Outlook, By Hormonal Disorders (2016-2026) ($MN)
  • Table 35 Global Injectable Drug Delivery Market Outlook, By Anemia (2016-2026) ($MN)
  • Table 36 Global Injectable Drug Delivery Market Outlook, By Antithrombotic/Thrombolytic Therapy (2016-2026) ($MN)
  • Table 37 Global Injectable Drug Delivery Market Outlook, By Growth Hormone Deficiency (GHD) (2016-2026) ($MN)
  • Table 38 Global Injectable Drug Delivery Market Outlook, By Diabetes (2016-2026) ($MN)
  • Table 39 Global Injectable Drug Delivery Market Outlook, By Osteoporosis (2016-2026) ($MN)
  • Table 40 Global Injectable Drug Delivery Market Outlook, By Reproductive Health Disease (2016-2026) ($MN)
  • Table 41 Global Injectable Drug Delivery Market Outlook, By Autoimmune Diseases (2016-2026) ($MN)
  • Table 42 Global Injectable Drug Delivery Market Outlook, By Multiple Sclerosis (MS) (2016-2026) ($MN)
  • Table 43 Global Injectable Drug Delivery Market Outlook, By Psoriasis (2016-2026) ($MN)
  • Table 44 Global Injectable Drug Delivery Market Outlook, By Rheumatoid Arthritis (2016-2026) ($MN)
  • Table 45 Global Injectable Drug Delivery Market Outlook, By Crohn's Disease (2016-2026) ($MN)
  • Table 46 Global Injectable Drug Delivery Market Outlook, By Other Autoimmune Diseases (2016-2026) ($MN)
  • Table 47 Global Injectable Drug Delivery Market Outlook, By Cancer (2016-2026) ($MN)
  • Table 48 Global Injectable Drug Delivery Market Outlook, By Orphan Diseases (2016-2026) ($MN)
  • Table 49 Global Injectable Drug Delivery Market Outlook, By Cardiovascular diseases (2016-2026) ($MN)
  • Table 50 Global Injectable Drug Delivery Market Outlook, By Neurology Addiction (2016-2026) ($MN)
  • Table 51 Global Injectable Drug Delivery Market Outlook, By Respiratory Diseases (2016-2026) ($MN)
  • Table 52 Global Injectable Drug Delivery Market Outlook, By Regenerative Medicine (2016-2026) ($MN)
  • Table 53 Global Injectable Drug Delivery Market Outlook, By Oncology (2016-2026) ($MN)
  • Table 54 Global Injectable Drug Delivery Market Outlook, By Other Therapeutic Applications (2016-2026) ($MN)
  • Table 55 Global Injectable Drug Delivery Market Outlook, By Aesthetic Treatment (2016-2026) ($MN)
  • Table 56 Global Injectable Drug Delivery Market Outlook, By Pain Management (2016-2026) ($MN)
  • Table 57 Global Injectable Drug Delivery Market Outlook, By Hemophilia (2016-2026) ($MN)
  • Table 58 Global Injectable Drug Delivery Market Outlook, By Hepatitis C (2016-2026) ($MN)
  • Table 59 Global Injectable Drug Delivery Market Outlook, By Allergies (2016-2026) ($MN)
  • Table 60 Global Injectable Drug Delivery Market Outlook, By Distribution Channel (2016-2026) ($MN)
  • Table 61 Global Injectable Drug Delivery Market Outlook, By Retail Pharmacy Stores (2016-2026) ($MN)
  • Table 62 Global Injectable Drug Delivery Market Outlook, By Hospitals (2016-2026) ($MN)
  • Table 63 Global Injectable Drug Delivery Market Outlook, By E-Commerce (2016-2026) ($MN)
  • Table 64 Global Injectable Drug Delivery Market Outlook, By End User (2016-2026) ($MN)
  • Table 65 Global Injectable Drug Delivery Market Outlook, By Ambulatory Care (2016-2026) ($MN)
  • Table 66 Global Injectable Drug Delivery Market Outlook, By Home Based (2016-2026) ($MN)
  • Table 67 Global Injectable Drug Delivery Market Outlook, By Clinics/Physician Offices (2016-2026) ($MN)
  • Table 68 Global Injectable Drug Delivery Market Outlook, By Other End Users (2016-2026) ($MN)

Note: Regional tables for North America, Europe, Asia Pacific, South America and Middle East & Africa are presented in similar manner as the above.

Back to Top